CLINICAL_TRIALS
trial_result
· 2025-02-24
Clinical Trial Update: Study of Efficacy and Safety of MEXIDOL® in Ischemic Stroke Therapy [Phase 3]
Summary
Phase 3 trial of MEXIDOL for ischemic stroke completed. Results assessing efficacy and safety have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pharmasoft | Conditions: Ischemic Stroke | Phase 3 | Status: COMPLETED | Results posted: 2025-02-24